Rene Salas

Board Member/Financial Expert at ADMA Biologics, Inc.

Speaker

Rene Salas serves as a member of the audit committee of ADMA Biologics, Inc. (NASDAQ: ADMA). Salas served as the chair of the nominating and governance committee and as a member of the audit committee of Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) prior to J&J’s $16.5 billion acquisition of ITCI in 2025. He was also formerly the lead independent director and audit committee chair of Embody, Inc., a private company that was acquired by Zimmer Biomet Holdings, Inc. (NYSE: ZBH). Salas served as a senior client serving partner of EY from 2002 until his retirement in 2019. As a retired EY audit partner and former CFO of a biotech company, Salas has extensive experience as a financial executive serving both publicly traded and privately-owned companies.

Salas is active in his community having served as chairman of several nonprofit boards. He currently serves as the audit committee chair of Northern Virginia Family Services and is on the advisory council to the Dean of the Alvarez College of Business at the University of Texas at San Antonio, his alma mater.